A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK
Phase 4
- Conditions
- MyopiaHyperopiaPresbyopia
- Interventions
- Device: Proscan, Zyoptix and Supracor
- Registration Number
- NCT01977807
- Lead Sponsor
- Technolas Perfect Vision GmbH
- Brief Summary
This clinical study has been planned to evaluate the safety and effectiveness of common treatment algorithms using 500 Hz laser repetition rate.
- Detailed Description
This clinical study has been planned to evaluate the safety and effectiveness of the excimer laser treatment algorithms Proscan, Zyoptix and Supracor of the 500 Hz laser system for ametropia and/or presbyopia when performed on the cornea of virgin eyes.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Myopia Proscan, Zyoptix and Supracor Myopia Lasik treatment of virgin eyes. Hyperopia Proscan, Zyoptix and Supracor Hyperopia Lasik treatment of virgin eyes.
- Primary Outcome Measures
Name Time Method For Proscan and Zyoptix: - The percentage of treated eyes within +/- 0.50D of target refraction. For Supracor: - The percentage of treated eyes with a best corrected high contrast distance VA of Snellen 20/25 (6/7.5 or 0.1 logMAR) or better Myopia: 6 months, Hyperopia 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Asian Eye Institut
🇵🇭Manila, Philippines